Momentum Stock Watch: Biolife Solutions (BLFS)

Company Profile:

BioLife Solutions, Inc. is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs. The Company’s product offerings include biopreservation media products for cells, tissues and organs; generic formulations of blood stem cell freezing media products; custom product formulation and custom packaging services; precision thermal packaging products and related Web applications; cell thawing media products, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. The Company markets its HypoThermosol FRS, CryoStor, generic BloodStor, biopreservation media products and SAVSU precision thermal packaging products to the biobanking, drug discovery and regenerative medicine markets. BioLife Solutions, Inc. was founded in 1987 and is based in Bothell, Washington.

Recent News:

BioLife Solutions (NASDAQ:BLFS) reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.10) by $0.02, AnalystRatingsNetwork.com reports. The business earned $1.50 million during the quarter, compared to analyst estimates of $1.60 million.

BioLife Products are Currently being used in approximately 200 Pre-Clinical Validation Projects and Clinical Trials.

Fundamental Analysis:

Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency.

Growth – Measures the growth of both the company’s income statement and cash flow.

@@@@@

Profitability – Measures the historical price movement of the stock.

@@@@@

Solvency – Measures the solvency of the company based on several ratios.

@@@@@

Efficiency – Measures the strength and historic growth of a company’s return on invested capital.

@@@@@

Conclusion:

BLFS’s strengths can be seen in its strong growth and profitability. Its revenue and net income have increased over several years. Technical indicators signal the bullish signs, as there is a bullish cross in Stochastic Oscillator. RSI is increasing to 49.81. The current P/BV ratio indicates it is undervalued compared to the average P/BV ratio of the industry and the sector. We rate BioLife Solutions, Inc. (BLFS) a STRONG BUY.